Skip to main content
Livermore
Livermore
ZHEN

Natixis

SEC CIK
0001274981
Latest filing
Aug 13, 2026

BMRN holding history

Biomarin Pharmaceutical Inc in every 13F filed by Natixis, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BMRN overviewAll 13F holders of BMRNFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
17
Since Q1 2021
Holdings of BMRN by Natixis, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−131,351−100.0%Sold outHolders
Q4 2025131,351$7.81M<0.1%+131,351NewHolders
Q3 20250$00.0%−4,742−100.0%Sold outHolders
Q2 20254,742$260.7K<0.1%+3,382+248.7%AddedHolders
Q1 20251,360$95.7K<0.1%+1,360NewHolders
Q4 20240$00.0%−79−100.0%Sold outHolders
Q3 202479$5.55K<0.1%+79NewHolders
Q2 20240$00.0%−40,315−100.0%Sold outHolders
Q1 202440,315$3.52M<0.1%−247,093−86.0%ReducedHolders
Q4 2023287,408$27.7M0.2%−211,293−42.4%ReducedHolders
Q3 2023498,701$44.1M0.3%+436,729+704.7%AddedHolders
Q2 202361,972$5.37M<0.1%−9,203−12.9%ReducedHolders
Q1 202371,175$6.92M0.1%−117−0.2%ReducedHolders
Q4 202271,292$7.38M<0.1%−147,336−67.4%ReducedHolders
Q3 2022218,628$18.5M0.1%−5,000−2.2%ReducedHolders
Q2 2022223,628$18.5M0.1%−619,214−73.5%ReducedHolders
Q1 2022842,842$65.0M0.2%−42,084−4.8%ReducedHolders
Q4 2021884,926$78.2M0.3%−407,019−31.5%ReducedHolders
Q3 20211,291,945$99.9M0.3%+79,355+6.5%AddedHolders
Q2 20211,212,590$101.2M0.4%+57,971+5.0%AddedHolders
Q1 20211,154,619$87.2M0.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.